Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
CATALYST PHARMACEUTICALS, INC.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CATALYST PHARMACEUTICALS, INC.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CATALYST PHARMACEUTICALS, INC.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CATALYST PHARMACEUTICALS, INC.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
CATALYST PHARMACEUTICALS, INC.Security delisted | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PDS Biotechnology CorpListing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
PDS Biotechnology CorpListing on record | AwardD (derivative) | $1.5M | SEC | ||
Insys Therapeutics, Inc.Listing unverified | Sell | $110.8K | SEC |